- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The global Biosimilars/follow-on-biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10730 million by 2025, from USD 9560.2 million in 2019.
The Biosimilars/follow-on-biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimilars/follow-on-biologics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Biosimilars/follow-on-biologics market has been segmented into Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Others, etc.
Breakdown by Application, Biosimilars/follow-on-biologics has been segmented into Blood disorders, Oncology diseases, Chronic and autoimmune diseases, Growth hormone deficiencies, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilars/follow-on-biologics market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilars/follow-on-biologics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilars/follow-on-biologics market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Biosimilars/follow-on-biologics Market Share Analysis
Biosimilars/follow-on-biologics competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Biosimilars/follow-on-biologics revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilars/follow-on-biologics revenue and market share for each player covered in this report.
The major players covered in Biosimilars/follow-on-biologics are: Novartis (Sandoz), Biogen idec, LG Life Sciences, Synthon Pharmaceuticals, Merck Serono (Merck), Teva Pharmaceutical Industries, Hospira, Celltrion Biocon, Genentech (Roche), etc. Among other players domestic and global, Biosimilars/follow-on-biologics market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Novartis (Sandoz)
Biogen idec
LG Life Sciences
Synthon Pharmaceuticals
Merck Serono (Merck)
Teva Pharmaceutical Industries
Hospira
Celltrion Biocon
Genentech (Roche)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Market segment by Application, can be divided into
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Biosimilars/follow-on-biologics
1.2 Classification of Biosimilars/follow-on-biologics by Type
1.2.1 Overview: Global Biosimilars/follow-on-biologics Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2019
1.2.3 Human growth hormone
1.2.4 Erythropoietin
1.2.5 Monoclonal antibodies
1.2.6 Insulin
1.2.7 Interferon
1.2.8 Granulocyte-Colony Stimulating Factor
1.2.9 Others
1.3 Global Biosimilars/follow-on-biologics Market by Application
1.3.1 Overview: Global Biosimilars/follow-on-biologics Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Global Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
1.5 Global Biosimilars/follow-on-biologics Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Biosimilars/follow-on-biologics Market Size by Regions (2015-2020)
1.7 Global Biosimilars/follow-on-biologics Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.7.2 Europe Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.7.3 Asia Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.7.4 South America Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis (Sandoz)
2.1.1 Novartis (Sandoz) Details
2.1.2 Novartis (Sandoz) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis (Sandoz) SWOT Analysis
2.1.4 Novartis (Sandoz) Product and Services
2.1.5 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen idec
2.2.1 Biogen idec Details
2.2.2 Biogen idec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen idec SWOT Analysis
2.2.4 Biogen idec Product and Services
2.2.5 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.3 LG Life Sciences
2.3.1 LG Life Sciences Details
2.3.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LG Life Sciences SWOT Analysis
2.3.4 LG Life Sciences Product and Services
2.3.5 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Synthon Pharmaceuticals
2.4.1 Synthon Pharmaceuticals Details
2.4.2 Synthon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Synthon Pharmaceuticals SWOT Analysis
2.4.4 Synthon Pharmaceuticals Product and Services
2.4.5 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck Serono (Merck)
2.5.1 Merck Serono (Merck) Details
2.5.2 Merck Serono (Merck) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck Serono (Merck) SWOT Analysis
2.5.4 Merck Serono (Merck) Product and Services
2.5.5 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries
2.6.1 Teva Pharmaceutical Industries Details
2.6.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical Industries SWOT Analysis
2.6.4 Teva Pharmaceutical Industries Product and Services
2.6.5 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hospira SWOT Analysis
2.7.4 Hospira Product and Services
2.7.5 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celltrion Biocon
2.8.1 Celltrion Biocon Details
2.8.2 Celltrion Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Celltrion Biocon SWOT Analysis
2.8.4 Celltrion Biocon Product and Services
2.8.5 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genentech (Roche)
2.9.1 Genentech (Roche) Details
2.9.2 Genentech (Roche) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genentech (Roche) SWOT Analysis
2.9.4 Genentech (Roche) Product and Services
2.9.5 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biosimilars/follow-on-biologics Market Size by Players (2015-2020)
3.2 China Biosimilars/follow-on-biologics Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Biosimilars/follow-on-biologics Players Market Share
3.3.2 Top 10 Biosimilars/follow-on-biologics Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Biosimilars/follow-on-biologics Market Size by Countries (2015-2020)
4.2 North America Biosimilars/follow-on-biologics Market Size and Forecast by Countries (2015-2026)
4.3 United States Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
4.4 Canada Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
4.5 Mexico Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Biosimilars/follow-on-biologics Market Size by Countries (2015-2020)
5.2 Europe Biosimilars/follow-on-biologics Market Size and Forecast by Countries (2015-2026)
5.3 Germany Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
5.4 France Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
5.5 UK Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
5.6 Russia Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
5.7 Italy Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Regions (2015-2020)
6.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size and Forecast by Regions (2015-2026)
6.3 China Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
6.4 Japan Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
6.5 Korea Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
6.6 India Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
6.7 Southeast Asia Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Biosimilars/follow-on-biologics Market Size by Countries (2015-2020)
7.2 South America Biosimilars/follow-on-biologics Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
7.4 Argentina Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Regions (2015-2020)
8.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
8.4 UAE Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
8.5 Egypt Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
8.6 South Africa Biosimilars/follow-on-biologics Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Biosimilars/follow-on-biologics Market Size and Forecast by Type (2015-2025)
9.1.1 Global Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
9.1.2 Global Biosimilars/follow-on-biologics Market Size Forecast by Type (2020-2025)
9.2 China Biosimilars/follow-on-biologics Market Size and Forecast by Type (2015-2025)
9.2.1 China Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
9.2.2 China Biosimilars/follow-on-biologics Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Biosimilars/follow-on-biologics Market Size and Forecast by Application (2015-2025)
10.1.1 Global Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
10.1.2 Global Biosimilars/follow-on-biologics Market Size Forecast by Application (2020-2025)
10.2 China Biosimilars/follow-on-biologics Market Size and Forecast by Application (2015-2025)
10.2.1 China Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
10.2.2 China Biosimilars/follow-on-biologics Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Biosimilars/follow-on-biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Biosimilars/follow-on-biologics Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Biosimilars/follow-on-biologics Revenue Share by Regions (2015-2020)
Table 7. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Biosimilars/follow-on-biologics Revenue Market Share by Regions (2020-2025)
Table 9. Novartis (Sandoz) Corporate Information, Location and Competitors
Table 10. Novartis (Sandoz) Major Business
Table 11. Novartis (Sandoz) Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 12. Novartis (Sandoz) SWOT Analysis
Table 13. Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Solutions
Table 14. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Biogen idec Corporate Information, Location and Competitors
Table 16. Biogen idec Major Business
Table 17. Biogen idec Biosimilars/follow-on-biologics Total Revenue (USD Million) (2018-2019)
Table 18. Biogen idec SWOT Analysis
Table 19. Biogen idec Biosimilars/follow-on-biologics Product and Solutions
Table 20. Biogen idec Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. LG Life Sciences Corporate Information, Location and Competitors
Table 22. LG Life Sciences Major Business
Table 23. LG Life Sciences Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 24. LG Life Sciences SWOT Analysis
Table 25. LG Life Sciences Biosimilars/follow-on-biologics Product and Solutions
Table 26. LG Life Sciences Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Synthon Pharmaceuticals Corporate Information, Location and Competitors
Table 28. Synthon Pharmaceuticals Major Business
Table 29. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 30. Synthon Pharmaceuticals SWOT Analysis
Table 31. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Solutions
Table 32. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Merck Serono (Merck) Corporate Information, Location and Competitors
Table 34. Merck Serono (Merck) Major Business
Table 35. Merck Serono (Merck) Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 36. Merck Serono (Merck) SWOT Analysis
Table 37. Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Solutions
Table 38. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 40. Teva Pharmaceutical Industries Major Business
Table 41. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 42. Teva Pharmaceutical Industries SWOT Analysis
Table 43. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Solutions
Table 44. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Hospira Corporate Information, Location and Competitors
Table 46. Hospira Major Business
Table 47. Hospira Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 48. Hospira SWOT Analysis
Table 49. Hospira Biosimilars/follow-on-biologics Product and Solutions
Table 50. Hospira Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Celltrion Biocon Corporate Information, Location and Competitors
Table 52. Celltrion Biocon Major Business
Table 53. Celltrion Biocon Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 54. Celltrion Biocon SWOT Analysis
Table 55. Celltrion Biocon Biosimilars/follow-on-biologics Product and Solutions
Table 56. Celltrion Biocon Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. Genentech (Roche) Corporate Information, Location and Competitors
Table 58. Genentech (Roche) Major Business
Table 59. Genentech (Roche) Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 60. Genentech (Roche) SWOT Analysis
Table 61. Genentech (Roche) Biosimilars/follow-on-biologics Product and Solutions
Table 62. Genentech (Roche) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Players (2015-2020)
Table 64. Global Biosimilars/follow-on-biologics Revenue Share by Players (2015-2020)
Table 65. Key Players Biosimilars/follow-on-biologics Revenue (USD Million) in China (2015-2020)
Table 66. Key Players Biosimilars/follow-on-biologics Revenue Share in China (2015-2020)
Table 67. North America Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2015-2020)
Table 68. North America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 69. North America Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2020-2026)
Table 70. North America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2020-2026)
Table 71. Europe Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2015-2020)
Table 72. Europe Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 73. Europe Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2020-2026)
Table 74. Europe Biosimilars/follow-on-biologics Revenue Market Share by Countries (2020-2026)
Table 75. Asia-Pacific Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2015-2020)
Table 76. Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 77. Asia-Pacific Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2020-2026)
Table 78. Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Share by Countries (2020-2026)
Table 79. South America Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2015-2020)
Table 80. South America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 81. South America Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2020-2026)
Table 82. South America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2020-2026)
Table 83. Middle East & Africa Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2015-2020)
Table 84. Middle East & Africa Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 85. Middle East & Africa Biosimilars/follow-on-biologics Revenue (USD Million) by Countries (2020-2026)
Table 86. Middle East & Africa Biosimilars/follow-on-biologics Revenue Market Share by Countries (2020-2026)
Table 87. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Type (2015-2020)
Table 88. Global Biosimilars/follow-on-biologics Revenue Share by Type (2015-2020)
Table 89. Global Biosimilars/follow-on-biologics Revenue Forecast by Type (2020-2025)
Table 90. Global Biosimilars/follow-on-biologics Market Share Forecast by Type (2020-2025)
Table 91. China Biosimilars/follow-on-biologics Revenue (USD Million) by Type (2015-2020)
Table 92. China Biosimilars/follow-on-biologics Revenue Share by Type (2015-2020)
Table 93. China Biosimilars/follow-on-biologics Revenue Forecast by Type (2020-2025)
Table 94. China Biosimilars/follow-on-biologics Market Share Forecast by Type (2020-2025)
Table 95. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Application (2015-2020)
Table 96. Global Biosimilars/follow-on-biologics Revenue Share by Application (2015-2020)
Table 97. Global Biosimilars/follow-on-biologics Revenue Forecast by Application (2020-2025)
Table 98. Global Biosimilars/follow-on-biologics Market Share Forecast by Application (2020-2025)
Table 99. China Biosimilars/follow-on-biologics Revenue (USD Million) by Application (2015-2020)
Table 100. China Biosimilars/follow-on-biologics Revenue Share by Application (2015-2020)
Table 101. China Biosimilars/follow-on-biologics Revenue Forecast by Application (2020-2025)
Table 102. China Biosimilars/follow-on-biologics Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Biosimilars/follow-on-biologics Picture
Figure 2. Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2019
Figure 4. Human growth hormone Picture
Figure 5. Erythropoietin Picture
Figure 6. Monoclonal antibodies Picture
Figure 7. Insulin Picture
Figure 8. Interferon Picture
Figure 9. Granulocyte-Colony Stimulating Factor Picture
Figure 10. Others Picture
Figure 11. Biosimilars/follow-on-biologics Revenue Market Share by Application in 2019
Figure 12. Blood disorders Picture
Figure 13. Oncology diseases Picture
Figure 14. Chronic and autoimmune diseases Picture
Figure 15. Growth hormone deficiencies Picture
Figure 16. Others Picture
Figure 17. Global Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2025) (USD Million)
Figure 18. Global Biosimilars/follow-on-biologics Market Size Share by Regions (2015-2025)
Figure 19. Global Biosimilars/follow-on-biologics Market Size Share by Regions in 2019
Figure 20. Global Biosimilars/follow-on-biologics Revenue Market Share by Regions (2020-2025)
Figure 21. North America Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 22. Europe Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 23. Asia-Pacific Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 24. South America Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 25. Middle East & Africa Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 26. Global Biosimilars/follow-on-biologics Revenue Share by Players in 2019
Figure 27. Global Top 5 Players Biosimilars/follow-on-biologics Revenue Market Share in 2019
Figure 28. Top 10 Players Biosimilars/follow-on-biologics Revenue Market Share in Global Market in 2019
Figure 29. Global Biosimilars/follow-on-biologics Market Size (USD Million) by Type (2015-2025)
Figure 30. Global Biosimilars/follow-on-biologics Market Size Share by Application (2015-2025)
Figure 31. North America Biosimilars/follow-on-biologics Market Size Share by Countries (2015-2025)
Figure 32. North America Biosimilars/follow-on-biologics Market Size Share by Countries in 2019
Figure 33. United States Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 34. Canada Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Mexico Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Europe Biosimilars/follow-on-biologics Market Size Share by Countries (2015-2025)
Figure 37. Europe Biosimilars/follow-on-biologics Market Size Share by Countries in 2019
Figure 38. Germany Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 39. France Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 40. Russia Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 41. Italy Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Spain Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 43. UK Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 44. Asia Biosimilars/follow-on-biologics Market Size Share by Countries (2015-2025)
Figure 45. Asia Biosimilars/follow-on-biologics Market Size Share by Countries in 2019
Figure 46. China Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 47. Japan Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 48. Korea Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 49. India Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 50. Southeast Asia Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 51. South America Biosimilars/follow-on-biologics Market Size Share by Countries (2015-2025)
Figure 52. South America Biosimilars/follow-on-biologics Market Size Share by Countries in 2019
Figure 53. Brazil Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 54. Argentina Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 55. Middle East & Africa Biosimilars/follow-on-biologics Market Size Share by Countries (2015-2025)
Figure 56. Middle East & Africa Biosimilars/follow-on-biologics Market Size Share by Countries in 2019
Figure 57. Saudi Arabia Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 58. UAE Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 59. Egypt Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 60. South Africa Biosimilars/follow-on-biologics Market Size (USD Million) and Forecast (2015-2025)
Figure 61. Global Biosimilars/follow-on-biologics Revenue Share by Type (2015-2020)
Figure 62. China Biosimilars/follow-on-biologics Revenue Share by Type (2015-2020)
Figure 63. Global Biosimilars/follow-on-biologics Revenue Share by Application (2015-2020)
Figure 64. China Biosimilars/follow-on-biologics Revenue Share by Application (2015-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
